Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives

[Display omitted] Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2021-09, Vol.47, p.128216-128216, Article 128216
Hauptverfasser: Eagon, Scott, Hammill, Jared T., Fitzsimmons, Kasey, Sienko, Natalie, Nguyen, Brandon, Law, Jarvis, Manjunath, Aashrita, Wilkinson, Steven P., Thompson, Kara, Glidden, Julia Elizabeth, Rice, Amy L., Falade, Mofolusho O., Kimball, Joshua J., DiBernardo, Celine, Guy, R. Kiplin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 128216
container_issue
container_start_page 128216
container_title Bioorganic & medicinal chemistry letters
container_volume 47
creator Eagon, Scott
Hammill, Jared T.
Fitzsimmons, Kasey
Sienko, Natalie
Nguyen, Brandon
Law, Jarvis
Manjunath, Aashrita
Wilkinson, Steven P.
Thompson, Kara
Glidden, Julia Elizabeth
Rice, Amy L.
Falade, Mofolusho O.
Kimball, Joshua J.
DiBernardo, Celine
Guy, R. Kiplin
description [Display omitted] Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of Plasmodium falciparum . While the initial lead compound displayed significant toxicity in a human cell proliferation assay, we were able to identify a derivative with no detectable toxicity and sub-micromolar potency.
doi_str_mv 10.1016/j.bmcl.2021.128216
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2544458895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X21004431</els_id><sourcerecordid>2544458895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-2850714cf50596a0172ac22aee542939279cdf845fddfc7a95c81a098939ef383</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlb_gAvp0oVTbzLJTAJuSvEFBTcK7kKa3MGUedRkWhx_vVOmunR1F_c7B85HyCWFGQWa3a5nq8qWMwaMziiTjGZHZEx5xpOUgzgmY1AZJFLx9xE5i3ENQDlwfkpGKaciTxWMyWJet74ypQnelFNjW7_zbTdtiim7yRLnV1h_d6V3WKPtbNl84JepmxqnDoPfmR7HeE5OClNGvDjcCXl7uH9dPCXLl8fnxXyZWA7QJkwKyCm3hQChMgM0Z8YyZhAFZypVLFfWFZKLwrnC5kYJK6kBJfsfFqlMJ-R66N2E5nOLsdWVjxbL0tTYbKNmgnMupFSiR9mA2tDEGLDQm9DPDJ2moPfy9Frv5em9PD3I60NXh_7tqkL3F_m11QN3A4D9yp3HoKP1WFt0PqBttWv8f_0_GUt_sw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2544458895</pqid></control><display><type>article</type><title>Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Eagon, Scott ; Hammill, Jared T. ; Fitzsimmons, Kasey ; Sienko, Natalie ; Nguyen, Brandon ; Law, Jarvis ; Manjunath, Aashrita ; Wilkinson, Steven P. ; Thompson, Kara ; Glidden, Julia Elizabeth ; Rice, Amy L. ; Falade, Mofolusho O. ; Kimball, Joshua J. ; DiBernardo, Celine ; Guy, R. Kiplin</creator><creatorcontrib>Eagon, Scott ; Hammill, Jared T. ; Fitzsimmons, Kasey ; Sienko, Natalie ; Nguyen, Brandon ; Law, Jarvis ; Manjunath, Aashrita ; Wilkinson, Steven P. ; Thompson, Kara ; Glidden, Julia Elizabeth ; Rice, Amy L. ; Falade, Mofolusho O. ; Kimball, Joshua J. ; DiBernardo, Celine ; Guy, R. Kiplin</creatorcontrib><description>[Display omitted] Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of Plasmodium falciparum . While the initial lead compound displayed significant toxicity in a human cell proliferation assay, we were able to identify a derivative with no detectable toxicity and sub-micromolar potency.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2021.128216</identifier><identifier>PMID: 34157390</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>2,6-Dibenzylidenecyclohexanone ; Antimalarials - chemical synthesis ; Antimalarials - chemistry ; Antimalarials - pharmacology ; Cell Proliferation - drug effects ; Chloroquine - chemical synthesis ; Chloroquine - chemistry ; Chloroquine - pharmacology ; Dose-Response Relationship, Drug ; Fibroblasts - drug effects ; Humans ; Malaria ; Michael system ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum ; Plasmodium falciparum - drug effects ; Structure activity relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2021-09, Vol.47, p.128216-128216, Article 128216</ispartof><rights>2021 The Author(s)</rights><rights>Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-2850714cf50596a0172ac22aee542939279cdf845fddfc7a95c81a098939ef383</citedby><cites>FETCH-LOGICAL-c400t-2850714cf50596a0172ac22aee542939279cdf845fddfc7a95c81a098939ef383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2021.128216$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34157390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eagon, Scott</creatorcontrib><creatorcontrib>Hammill, Jared T.</creatorcontrib><creatorcontrib>Fitzsimmons, Kasey</creatorcontrib><creatorcontrib>Sienko, Natalie</creatorcontrib><creatorcontrib>Nguyen, Brandon</creatorcontrib><creatorcontrib>Law, Jarvis</creatorcontrib><creatorcontrib>Manjunath, Aashrita</creatorcontrib><creatorcontrib>Wilkinson, Steven P.</creatorcontrib><creatorcontrib>Thompson, Kara</creatorcontrib><creatorcontrib>Glidden, Julia Elizabeth</creatorcontrib><creatorcontrib>Rice, Amy L.</creatorcontrib><creatorcontrib>Falade, Mofolusho O.</creatorcontrib><creatorcontrib>Kimball, Joshua J.</creatorcontrib><creatorcontrib>DiBernardo, Celine</creatorcontrib><creatorcontrib>Guy, R. Kiplin</creatorcontrib><title>Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of Plasmodium falciparum . While the initial lead compound displayed significant toxicity in a human cell proliferation assay, we were able to identify a derivative with no detectable toxicity and sub-micromolar potency.</description><subject>2,6-Dibenzylidenecyclohexanone</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - pharmacology</subject><subject>Cell Proliferation - drug effects</subject><subject>Chloroquine - chemical synthesis</subject><subject>Chloroquine - chemistry</subject><subject>Chloroquine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fibroblasts - drug effects</subject><subject>Humans</subject><subject>Malaria</subject><subject>Michael system</subject><subject>Molecular Structure</subject><subject>Parasitic Sensitivity Tests</subject><subject>Plasmodium falciparum</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Structure activity relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotlb_gAvp0oVTbzLJTAJuSvEFBTcK7kKa3MGUedRkWhx_vVOmunR1F_c7B85HyCWFGQWa3a5nq8qWMwaMziiTjGZHZEx5xpOUgzgmY1AZJFLx9xE5i3ENQDlwfkpGKaciTxWMyWJet74ypQnelFNjW7_zbTdtiim7yRLnV1h_d6V3WKPtbNl84JepmxqnDoPfmR7HeE5OClNGvDjcCXl7uH9dPCXLl8fnxXyZWA7QJkwKyCm3hQChMgM0Z8YyZhAFZypVLFfWFZKLwrnC5kYJK6kBJfsfFqlMJ-R66N2E5nOLsdWVjxbL0tTYbKNmgnMupFSiR9mA2tDEGLDQm9DPDJ2moPfy9Frv5em9PD3I60NXh_7tqkL3F_m11QN3A4D9yp3HoKP1WFt0PqBttWv8f_0_GUt_sw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Eagon, Scott</creator><creator>Hammill, Jared T.</creator><creator>Fitzsimmons, Kasey</creator><creator>Sienko, Natalie</creator><creator>Nguyen, Brandon</creator><creator>Law, Jarvis</creator><creator>Manjunath, Aashrita</creator><creator>Wilkinson, Steven P.</creator><creator>Thompson, Kara</creator><creator>Glidden, Julia Elizabeth</creator><creator>Rice, Amy L.</creator><creator>Falade, Mofolusho O.</creator><creator>Kimball, Joshua J.</creator><creator>DiBernardo, Celine</creator><creator>Guy, R. Kiplin</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210901</creationdate><title>Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives</title><author>Eagon, Scott ; Hammill, Jared T. ; Fitzsimmons, Kasey ; Sienko, Natalie ; Nguyen, Brandon ; Law, Jarvis ; Manjunath, Aashrita ; Wilkinson, Steven P. ; Thompson, Kara ; Glidden, Julia Elizabeth ; Rice, Amy L. ; Falade, Mofolusho O. ; Kimball, Joshua J. ; DiBernardo, Celine ; Guy, R. Kiplin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-2850714cf50596a0172ac22aee542939279cdf845fddfc7a95c81a098939ef383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>2,6-Dibenzylidenecyclohexanone</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - pharmacology</topic><topic>Cell Proliferation - drug effects</topic><topic>Chloroquine - chemical synthesis</topic><topic>Chloroquine - chemistry</topic><topic>Chloroquine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fibroblasts - drug effects</topic><topic>Humans</topic><topic>Malaria</topic><topic>Michael system</topic><topic>Molecular Structure</topic><topic>Parasitic Sensitivity Tests</topic><topic>Plasmodium falciparum</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Structure activity relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eagon, Scott</creatorcontrib><creatorcontrib>Hammill, Jared T.</creatorcontrib><creatorcontrib>Fitzsimmons, Kasey</creatorcontrib><creatorcontrib>Sienko, Natalie</creatorcontrib><creatorcontrib>Nguyen, Brandon</creatorcontrib><creatorcontrib>Law, Jarvis</creatorcontrib><creatorcontrib>Manjunath, Aashrita</creatorcontrib><creatorcontrib>Wilkinson, Steven P.</creatorcontrib><creatorcontrib>Thompson, Kara</creatorcontrib><creatorcontrib>Glidden, Julia Elizabeth</creatorcontrib><creatorcontrib>Rice, Amy L.</creatorcontrib><creatorcontrib>Falade, Mofolusho O.</creatorcontrib><creatorcontrib>Kimball, Joshua J.</creatorcontrib><creatorcontrib>DiBernardo, Celine</creatorcontrib><creatorcontrib>Guy, R. Kiplin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eagon, Scott</au><au>Hammill, Jared T.</au><au>Fitzsimmons, Kasey</au><au>Sienko, Natalie</au><au>Nguyen, Brandon</au><au>Law, Jarvis</au><au>Manjunath, Aashrita</au><au>Wilkinson, Steven P.</au><au>Thompson, Kara</au><au>Glidden, Julia Elizabeth</au><au>Rice, Amy L.</au><au>Falade, Mofolusho O.</au><au>Kimball, Joshua J.</au><au>DiBernardo, Celine</au><au>Guy, R. Kiplin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>47</volume><spage>128216</spage><epage>128216</epage><pages>128216-128216</pages><artnum>128216</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of Plasmodium falciparum . While the initial lead compound displayed significant toxicity in a human cell proliferation assay, we were able to identify a derivative with no detectable toxicity and sub-micromolar potency.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34157390</pmid><doi>10.1016/j.bmcl.2021.128216</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2021-09, Vol.47, p.128216-128216, Article 128216
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_2544458895
source MEDLINE; Elsevier ScienceDirect Journals
subjects 2,6-Dibenzylidenecyclohexanone
Antimalarials - chemical synthesis
Antimalarials - chemistry
Antimalarials - pharmacology
Cell Proliferation - drug effects
Chloroquine - chemical synthesis
Chloroquine - chemistry
Chloroquine - pharmacology
Dose-Response Relationship, Drug
Fibroblasts - drug effects
Humans
Malaria
Michael system
Molecular Structure
Parasitic Sensitivity Tests
Plasmodium falciparum
Plasmodium falciparum - drug effects
Structure activity relationship
title Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A05%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimalarial%20activity%20of%202,6-dibenzylidenecyclohexanone%20derivatives&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Eagon,%20Scott&rft.date=2021-09-01&rft.volume=47&rft.spage=128216&rft.epage=128216&rft.pages=128216-128216&rft.artnum=128216&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2021.128216&rft_dat=%3Cproquest_cross%3E2544458895%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2544458895&rft_id=info:pmid/34157390&rft_els_id=S0960894X21004431&rfr_iscdi=true